Ayuda
Ir al contenido

Dialnet


Adrenal Imaging

  • Autores: Mishal Mendiratta-Lala, Anca Avram, Adina F. Turcu, N.Reed Dunnick
  • Localización: Endocrinology and metabolism clinics of North America, ISSN 0889-8529, Vol. 46, Nº. 3, 2017 (Ejemplar dedicado a: Biochemical and Imaging Diagnostics in Endocrinology), págs. 741-759
  • Idioma: inglés
  • Texto completo no disponible (Saber más ...)
  • Resumen
    • Cross-sectional imaging can make a specific diagnosis in lesions, such as myelolipomas, cysts, and hemorrhage, and is often sufficient to distinguish benign from malignant adrenal processes. CT and MRI are useful studies to identify pheochromocytomas and cortisol-secreting or androgen-secreting tumors. In patients with primary aldosteronism, adrenal venous sampling remains the most accurate localizing study and should be performed in all patients older than 35. Radiolabeled isotope studies serve as second-line diagnostic tests for malignant adrenal tumors, primary or metastatic, as well as for pheochromocytoma. Nuclear imaging studies should follow a robust hormonal diagnosis and be correlated with findings on cross-sectional imaging.


Fundación Dialnet

Dialnet Plus

  • Más información sobre Dialnet Plus

Opciones de compartir

Opciones de entorno